source
- Latus Bio secures $42 million to launch Huntington’s disease gene therapy trialBiotech startup Latus Bio announced it has raised $42 million to fund its first clinical trials, including a gene‑therapy program aimed at Huntington’s disease. The capital will be used to seek FDA…
- AI drug repurposing in oncology hampered by fragmented data, curated knowledge neededAI tools are being used to look for new cancer indications for existing biologics, but the article notes that fragmented and disparate data sets limit even the most advanced models. Repurposing pr…